Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor in COPD (The Topic Trial)
NCT03085485Phase 2Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Mar 2017
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivacaftor in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by University of Alabama at Birmingham. Started Mar 2017; status: completed.
02
Drugs
ivacaftor
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT03085485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085485.